Gilead has the cure for Hepatitis C (HCV) known as Sofosbuvir, which is taken alone or in combination with other drugs. Now we need a cure for Gilead. By pressing the company to make Sofosbuvir-based therapies accessible to all who need them, the Hepatitis C epidemic in America and worldwide can be brought to an end. The lives of 5 million HCV-infected Americans and an estimated 160 million HCV-infected people worldwide are at stake.
- Earth 2.0: Is Income Inequality Inevitable?
- Will Economic Illiteracy Trigger a Trade War?
- How Trump could make US a climate pariah over Paris pact
- Earth 2.0: What Would Our Economy Look Like?
- Our misguided ‘wars of choice’